Cargando…
Registry Study Describes COVID‐19 Mortality and Hospitalization in Patients with Breast Cancer
Nearly half (48%) of patients with active breast cancer or a history of breast cancer and COVID‐19 were hospitalized and 9% died within 30 days of COVID‐19 diagnosis, according to new data from the COVID‐19 and Cancer Consortium registry study.
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869358/ https://www.ncbi.nlm.nih.gov/pubmed/33399255 http://dx.doi.org/10.1002/onco.13664 |
Ejemplares similares
-
ASH Registry Offers Insights on COVID‐19 in Patients with Hematologic Malignancies
Publicado: (2020) -
Breast Cancer Chemotherapy Can Be Administered Safely During the COVID‐19 Pandemic
Publicado: (2021) -
COVID‐19 Pandemic Effects on Breast Cancer Diagnosis in Croatia: A Population‐ and Registry‐Based Study
por: Vrdoljak, Eduard, et al.
Publicado: (2021) -
A working taxonomy for describing the sensory differences of autism
por: He, Jason L., et al.
Publicado: (2023) -
Developing current procedural terminology codes that describe the work performed by machines
por: Frank, Richard A., et al.
Publicado: (2022)